Biolux Research has completed a new clinical study using a shorter, more efficient, photobiomodulation treatment protocol to increase implant stability after surgery.
The clinical study was completed at the University of Toronto as a student's Master of Science thesis in the graduate department of dentistry. The study investigated the efficacy of a new treatment protocol for the OsseoPulse, Biolux's approved photobiomodulation product, on implant stability.
The new treatment protocol consists of a preoperative 20-minute phototherapy session on the day of surgery, followed by daily phototherapy sessions for the next 10 days, compared with the original 21-day treatment protocol.
The results of the study show an increase in implant stability starting from day zero for the treated group, compared with the typical decrease in implant stability in the first few weeks after placement, as shown in the control group. The increase in implant stability with the new protocol suggests a reduced risk of implant failure and the potential for earlier or immediate loading of implants, according to the company.
The materials are now available on the Biolux website.
